Anaadriana Zakarija

Personal profile

Research Interests

The diagnosis and treatment of bleeding disorders and their complications. Evaluation of causes of thrombosis and education regarding treatment and prevention of thrombosis.

Certifications and Licenses

	Medical Oncology
	Hematology

Training Experience

2000	Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)
2004	Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, Rush Medical Collage

… → 1997

Research interests

Anemia
Hematology
Thrombosis/Fibrinolysis
Blood and Bleeding Disorders (anemia, clotting, etc.)

Fingerprint Dive into the research topics where Anaadriana Zakarija is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

1 Active
22 Finished

Community Counts: Public Health Surveillance for Bleeding Disorders

Zakarija, A.

Great Lakes Hemophilia Foundation, Centers for Disease Control and Prevention

9/30/15 → 9/29/20

Project: Research project

Hemophilia Treatment Center (HRSA Award)

Zakarija, A.

Great Lakes Hemophilia Foundation, Health Resources and Services Administration

6/1/14 → 5/31/16

Project: Research project

ATHN Data Quality Counts Award Round 5.1

Zakarija, A.

American Thrombosis and Hemostasis Network

4/30/13 → 4/29/14

Project: Research project

Hemophilia Treatment Center (HRSA Award)

Zakarija, A.

Great Lakes Hemophilia Foundation, Health Resources and Services Administration

6/1/12 → 5/31/14

Project: Research project

Prevention of the Complications of Bleeding Through HTC's

Zakarija, A.

Great Lakes Hemophilia Foundation, Centers for Disease Control and Prevention

9/30/11 → 9/29/15

Project: Research project

Research Output

1053 Citations
17 Article
9 Review article
2 Chapter
1 Editorial

NCCN Guidelines^® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines

Streiff, M. B., Holmstrom, B., Angelini, D., Ashrani, A., Bockenstedt, P. L., Chesney, C., Fanikos, J., Fenninger, R. B., Fogerty, A. E., Gao, S., Goldhaber, S. Z., Gundabolu, K., Hendrie, P., Lee, A. I., Lee, J. T., Mann, J., McMahon, B., Millenson, M. M., Morton, C., Ortel, T. L. & 12 others, Ozair, S., Paschal, R., Shattil, S., Siddiqi, T., Smock, K. J., Soff, G., Wang, T. F., Williams, E., Zakarija, A., Hammond, L., Dwyer, M. A. & Engh, A. M., Nov 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 11, p. 1289-1303 15 p.